TrialATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease
Trial details
- Registry ID
- NCT04488419
- Phase
- Phase 2, Phase 3
LONA
LeonaBio
Company identity has not yet been verified
Browse linked trials and recorded changes, or follow this company for updates.
5Trials in this database
1Recorded changes · last 12 months
Partial coverageOnly the trials and history collected so far
Research sample: selected versions from May 2023 onward plus a preceding baseline where available. Only selected fields were retained; endpoint measures were truncated to 300 characters. This is not complete trial or sponsor history. Daily snapshots begin when collection starts.
Completion dates · Pro
Which trial dates moved later?
Pro summarizes how far estimated completion dates moved later and counts trials with edits to their main study measures, using the history available here. View Pro features
Included trials
Check company identity source| Trial | Sponsor | Phase | Status | Primary completion |
|---|---|---|---|---|
| ATH-1017 for Treatment of Mild to Moderate Alzheimer's DiseaseNCT04488419 | LeonaBio | Phase 2, Phase 3 | Completed | 2024-07-15Actual |
| A Study of ATH-1017 in Mild to Moderate Alzheimer's DiseaseNCT04491006 | LeonaBio | Phase 2 | Completed | 2022-05-20Actual |
| ATH-1017 Treatment in Subjects With Parkinson's Disease Dementia or Dementia With Lewy Bodies (SHAPE Trial)NCT04831281 | LeonaBio | Phase 2 | Terminated | 2023-04-19Actual |
| Open Label Study of ATH-1017 for Treatment of Mild to Moderate Alzheimer's DiseaseNCT04886063 | LeonaBio | Phase 2, Phase 3 | Terminated | 2024-10-23Actual |
| Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 MutationNCT05696626 | LeonaBio | Phase 3 | Recruiting | 2027-04Estimated |
A Study of ATH-1017 in Mild to Moderate Alzheimer's Disease
Trial details
- Registry ID
- NCT04491006
- Phase
- Phase 2
ATH-1017 Treatment in Subjects With Parkinson's Disease Dementia or Dementia With Lewy Bodies (SHAPE Trial)
Trial details
- Registry ID
- NCT04831281
- Phase
- Phase 2
Open Label Study of ATH-1017 for Treatment of Mild to Moderate Alzheimer's Disease
Trial details
- Registry ID
- NCT04886063
- Phase
- Phase 2, Phase 3
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
Trial details
- Registry ID
- NCT05696626
- Phase
- Phase 3
Latest recorded trial changes
Evaluation of Lasofoxifene Combined With Abemaciclib Compared With Fulvestrant Combined With Abemaciclib in Locally Advanced or Metastatic ER+/HER2- Breast Cancer With an ESR1 Mutation
NCT05696626 · LeonaBio
Planned enrollment increased by 100 participants
− Before
500 participants (planned)
+ After
600 participants (planned)